.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2014 for a tremendous $4...
.On the heels of a stage 3 win that stopped working to impress investors, Ironwood Pharmaceuticals i...
.Don't stop Monte Rosa Therapies right now. The Boston-based biotech is actually enjoying after sign...
.Invite to recently's Chutes & Ladders, our roundup of significant leadership hirings, shootings ...
.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...
.AbbVie has returned to the source of its antipsychotic powerhouse Vraylar searching for another run...
.GenSight Biologics is actually full weeks far from lacking funds. Again. The biotech simply possess...
.Monopar Rehabs is recuperating a drug from the dump of AstraZeneca's unusual health condition pipe....
.With brand new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of analysts e...
.After forming a gene treatment relationship along with Dyno Rehabs in 2020, Roche is back for addit...